carbon monoxide has been researched along with Chronic Pain in 5 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
Chronic Pain: Aching sensation that persists for more than a few months. It may or may not be associated with trauma or disease, and may persist after the initial injury has healed. Its localization, character, and timing are more vague than with acute pain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with a carbon monoxide-releasing molecule (tricarbonyldichlororuthenium(II) dimer, CORM-2) or a classical heme oxygenase 1 inducer (cobalt protoporphyrin IX, CoPP) has potent anti-inflammatory effects, but the role played by these treatments in the antinociceptive effects of morphine during acute and chronic pain was not evaluated." | 7.79 | Effects of treatment with a carbon monoxide-releasing molecule and a heme oxygenase 1 inducer in the antinociceptive effects of morphine in different models of acute and chronic pain in mice. ( Gou, G; Hervera, A; Leánez, S; Pol, O, 2013) |
| "Treatment with a carbon monoxide-releasing molecule (tricarbonyldichlororuthenium(II) dimer, CORM-2) or a classical heme oxygenase 1 inducer (cobalt protoporphyrin IX, CoPP) has potent anti-inflammatory effects, but the role played by these treatments in the antinociceptive effects of morphine during acute and chronic pain was not evaluated." | 3.79 | Effects of treatment with a carbon monoxide-releasing molecule and a heme oxygenase 1 inducer in the antinociceptive effects of morphine in different models of acute and chronic pain in mice. ( Gou, G; Hervera, A; Leánez, S; Pol, O, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cazuza, RA | 1 |
| Batallé, G | 1 |
| Bai, X | 1 |
| Leite-Panissi, CRA | 1 |
| Pol, O | 4 |
| LaRowe, LR | 1 |
| Kosiba, JD | 1 |
| Zale, EL | 1 |
| Ditre, JW | 1 |
| Hervera, A | 2 |
| Gou, G | 1 |
| Leánez, S | 2 |
| Negrete, R | 1 |
1 review available for carbon monoxide and Chronic Pain
| Article | Year |
|---|---|
The role of carbon monoxide, heme oxygenase 1, and the Nrf2 transcription factor in the modulation of chronic pain and their interactions with opioids and cannabinoids.
Topics: Analgesics, Opioid; Cannabinoids; Carbon Monoxide; Chronic Pain; Heme Oxygenase-1; Humans; NF-E2-Rel | 2021 |
1 trial available for carbon monoxide and Chronic Pain
| Article | Year |
|---|---|
Effects of nicotine deprivation on current pain intensity among daily cigarette smokers.
Topics: Adult; Carbon Monoxide; Chronic Pain; Cigarette Smoking; Cross-Sectional Studies; Female; Humans; Ma | 2018 |
3 other studies available for carbon monoxide and Chronic Pain